- IN₹502.06bn
- IN₹470.57bn
- IN₹64.31bn
India's GlaxoSmithKline Pharma hits record high
Indian pharma cos could see sustained margin expansion in near term - Bernstein
India's Gland Pharma surges after FDA concludes Hyderabad facility inspection
Brief: Gland Pharma Gets EIR From USFDA For Pashamylaram Facility
India's Gland Pharma rises on block deals
Brief: Gland Pharma Says Received Tentative Approval From US FDA For Angiotensin II Injection
Abbott India's Q2 profit climbs on strong sales
Brief: Gland Pharma Gets EIR From FDA For VSEZ Sterile Oncology Facility, Visakhapatnam
India's Gland Pharma rises on bets of strong growth outlook
India's Gland Pharma misses Q2 profit view on higher expenses
Brief: India's Gland Pharma Posts Sept-Quarter Consol Net Profit 1.94 Billion Rupees
India's Nifty Pharma up 1.3%, set to snap six-session losing streak
Brief: Gland Pharma Says FDA Concluded Inspection At Dundigal Facility
Refinitiv Newscasts - Asia Insight: Inflation in India is expected to break through the RBI's target
India's Gland Pharma surges 20% on quarterly revenue jump
India's Gland Pharma posts 41% jump in quarterly revenue on Cenexi acquisition
India's Gland Pharma up after USFDA inspection shows zero observations
Brief: Gland Pharma Says US FDA Conducted Good Manufacturing Practice Inspection at Co's VSEZ Sterile Oncology Facility
Brief: Gland Pharma Says U.S. FDA Conducted Good Manufacturing Practice Inspection At Dundigal Facility